MedCity News April 5, 2024
Biolinq raked in $58 million in capital this week. The company is developing a wearable patch that uses electrochemical sensors to measure a person’s glucose levels from the intradermal space just beneath the surface of their skin.
This week, San Diego-based company Biolinq raked in $58 million in a funding round led by Alpha Wave Ventures, bringing its total funding to date to $178 million.
The company, founded in 2012, is developing a wearable patch that leverages electrochemical sensors to measure a person’s glucose levels from the intradermal space just beneath the surface of their skin.
The papillary dermis — the top layer of the skin beneath the outermost layer — is the “ideal location for sensing any biomarker...
Today's Sponsors
Today's Sponsor